Pharmaceutical Business review

PERCIVIA appoints new CEO

Munshi is a co-founder and the former chief business officer of KYTHERA Biopharmaceuticals.

Before KYTHERA, Munshi was the general manager of Amgen’s European Nephrology Business, with responsibility for Amgen lead product for anemia management.

PERCIVIA board of directors member Stephan Tanda said Amit brings with him 20 years of experience building successful global businesses.

"He has demonstrated an entrepreneurial vision both in start-up environments and within larger corporate enterprises – making him uniquely suited to lead PERCIVIA," Tanda said.